Pattern Pharma is an immunotherapy company whose PAR-1 product systemically activates the innate immune system (dendritic cells, macrophages and NK cells) to fight cancers and infectious diseases.  PAR-1 is a significantly improved, patent-protected, next generation of an earlier product which received regulatory approval and has proven safe & efficacious on millions of patients in several indications. It is readily manufacturable and can be used as a single agent or in combination therapy.